Research - Blog

Demo Video: Ferma Search for HCP-Patient Conversations

Ferma-Powered Search is a game changer in harnessing patient-centric insights for strategic brand planning. This innovative search tool leverages the power of natural language processing through our Ferma healthcare AI algorithm to revolutionize

Oncology

Adaptive Follow-ups using Prompts and Generative AI for In-depth Insights

Primary Market Research (PMR) has come a long way. From what started as a paper-based quant survey to gauge consumer preferences in the 1920s, market research has undergone multiple paradigm shifts. We are

HCP-Pt

Improving Patient Centricity and Data-Driven Decision Making with Ferma Search for HCP-Patient Conversations

We are excited to announce a groundbreaking addition to Zoomrx's HCP-Pt Research offering: Ferma Search. This innovative search tool leverages the power of natural language processing via our Ferma healthcare AI algorithm to

News

ASCO 2023 : From the Oncologists’ Perspective

ASCO Annual Meeting 2023 led with the theme of Improving Patients' Lives Through Collaboration, Research, and Innovation, creating positive experiences among those who attended and generating excitement about practice-changing data. The ZoomRx survey

Oncology

Continuing the Launch Buzz: A Winning Game Plan

Three Keys for Sales Rep Conversations to Keep the Launch Momentum Going Introduction: Successfully launching a pharmaceutical product is incredibly challenging, time-consuming—and costly. The stakes are high, the competition is fierce, and

PERxCEPT

How Did Oncologists Engage With ASCO 2023 Online?

The American Society of Clinical Oncology (ASCO) Annual Meeting 2023, one of the most anticipated events in the oncology community, brought together healthcare professionals, researchers, and industry experts to exchange knowledge and advancements

Research

The Challenges of Managing Chronic Conditions

Section I: Introduction Chronic conditions are pervasive health issues that affect a significant portion of the global population. These conditions, such as diabetes, cardiovascular disease, asthma, and arthritis, require ongoing management to ensure

Launch Excellence

From Triumph to Competition: Humira's Journey and the Rise of Biosimilars

Humira, a name synonymous with swiss knife. It is a drug that could treat all conditions from Rheumatoid arthritis to Ulcerative Colitis. It is a blockbuster drug that rose to prominence amidst challenges

Research

Balancing Ethics and Innovation in Clinical Trials: A ZoomRx Resource for Healthcare Providers

Clinical trials are a crucial component of developing new treatments and therapies. They have the potential to shed light on the safety and efficacy of medical innovations. However, as with any type of

PERxCEPT

From Promotion to Prescription: Key Insights Connecting Online and Offline Promotional Activity

In today's fiercely competitive market, promotions play a crucial role in driving brand awareness, customer engagement, and ultimately, sales growth. To unravel the true impact of promotion across offline and online channels, we

Launch Excellence

Arexvy: A Promising Breakthrough in RSV Prevention for Older Adults

Introduction: ZoomRx is excited to share the latest developments regarding Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults. Recently approved by the US Food and Drug Administration (FDA), Arexvy

News

Navigating the Diabetes Space : Three Key Insights on HCP Traffic to Product Websites

Diabetes has become a significant public health concern, with over one in ten people affected by it worldwide. The diabetes space is highly competitive, with more than forty branded drugs in the market

News

The Rise of The “Skinny Jab"

Over the past year, the demand for weight loss medications has increased dramatically and so-called "skinny jab" drugs (GLP-1 receptor agonists Wegovy, Ozempic, and Mounjaro) have consistently struggled to avoid drug shortages. This

Launch Excellence

Transforming Post-HCT Care for Blood Cancer Patients - Insights from Oncologists

Introduction: Omisirge, the revolutionary stem cell therapy developed by Gamida Cell, has recently received FDA approval and is poised to revolutionize the post-HCT (hematopoietic stem cell transplantation) journey for patients with blood cancers.

News

The Power of Your Voice: How ZoomRx Helps Healthcare Providers Drive Pharma Market Research

The Power of Your Voice: How ZoomRx Helps Healthcare Providers Drive Pharma Market Research In today's rapidly evolving healthcare landscape, it is critical for pharmaceutical companies to gather timely and accurate feedback from

Oncology

Maximizing Oncologist Engagement: Insights into Driving Traffic to Brand Websites with PERxCEPT

Oncologists often turn to official product websites as a source of information to stay updated with the latest medical products and treatment options available to their patients. These websites provide valuable information on

Research

Meet the Top 5 Oncology Pharmaceutical Manufacturers that Excel with MSL Guidance

The oncology field is rapidly evolving, with groundbreaking CAR-T cell therapies and accessible biosimilars providing new hope for patients. However, these changes also bring new challenges in understanding and effectively utilizing these treatments.

Ferma

Exciting Insights and Findings Revealed in AUA 2023 Abstract Release!

For over a century, the American Urological Association (AUA) has been a leading organization dedicated to supporting the urological community. With more than 23,000 members worldwide, AUAs mission is to promote the

Digital

The Future of Telehealth: Emerging Trends and Innovations

Telehealth has come a long way since its inception, and the pandemic has accelerated its growth and adoption. With technology advancements and the increasing demand for remote healthcare services, telehealth is poised to

Research

Dermatologists and Rheumatologists Weigh In on Immunology Needs and Shifts in 2021

Across multiple indications, physicians anticipate 2021 will be an exciting year for advancing treatments across autoimmune and auto-inflammatory conditions. In a study conducted by ZoomRx late December 2020, 107 practicing U.S. rheumatologists

Covid-19

Impact of COVID-19 on Therapeutic Approaches to Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Understand how neurology departments across the US and Canada are rapidly adapting their clinical care delivery systems to minimize risk of SARS-CoV-2 transmission.

Covid-19

COVID-19: Physician Perspective on Efforts to Address Health Inequity

Evidence shows that the ongoing COVID-19 pandemic disproportionately impacts Black Americans. Here are some recommendations from physicians to advocate for heath equity.

Covid-19

COVID-19 Impact on US Commercial Payers

Throughout the COVID outbreak, health plans have collectively gone to great lengths to provide coverage in an urgent and unexpected situation. Plans have rapidly adapted to current healthcare needs...

Covid-19

COVID-19: Impact on Healthcare Practices and Treatment Decisions

The evolving COVID-19 pandemic is causing enormous impact on individuals and the healthcare system. Increasingly, it is also clear that COVID-19 has broad-ranging effects on our workplaces, our economy, and our social interactions.

Research

ZoomRx, MGH, and the Sumaira Foundation Collaborate on Newly Published NMO Research

When approached by the Global Neurology Research Group at Mass General Hospital (along with the Sumaira Foundation) with the opportunity to collaborate on a global study of neuromyelitis optica (NMO), we were eager